Bioconjugate Chemistry · 2004 · 77 citations · 4 references
MedicineNuclear MedicinePharmacologyCarbohydrate ChemistryMolecular ImagingRadionuclide TherapyConjugation ReactionsLigand BindingRadiopharmaceutical TherapyRadiopharmaceuticalsRadiotracer DevelopmentTumor ImagingDrug Conjugation PathwaysMolecular Imaging TracersMolecular Target ImagingRadioligand ImagingRadioligand Therapy ImagingRadionuclide ConjugationRadiotracer Labeling ChemistryRadiotracer Synthesis
An approach to a new class of potential radiopharmaceuticals is demonstrated by the labeling of a glucosamine derivative with the tricarbonyls of 99mTc and 186Re. The proligand HL2 (N-(2'-hydroxybenzyl)-2-amino-2-deoxy-D-glucose) was produced by hydrogenation of the corresponding Schiff base and reacted with [NEt4]2[Re(CO)3Br3] to form the neutral complex [(L2)Re(CO)3] in 40% yield. 1H and 13C NMR spectra indicate that the [Re(CO)3] core is bound in a tridentate fashion via the amino N, phenolato O, and C-3 hydroxyl O atoms of the ligand. At the tracer-level, labeling of HL2 with [99mTc(CO)3(H2O)3]+ and [186Re(CO)3(H2O)3]+ was achieved in aqueous conditions in 95 +/- 2% and 94 +/- 3% average radiochemical yields, respectively.
4
Roger Schibli, Roberto La Bella, Roger Alberto et al. · Bioconjugate Chemistry · 2000 · 360 citations
Medicine, Chemistry, Pharmacology +13
Roger Schibli, R. Schwarzbach, Roger Alberto et al. · Bioconjugate Chemistry · 2002 · 182 citations
J. Petrig, Roger Schibli, Cécile Dumas et al. · Chemistry - A European Journal · 2001 · 93 citations